BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lai Q, Di Martino M, Lucatelli P, Mennini G. Locoregional therapy response in patients with hepatocellular cancer waiting for liver transplantation: Only selection or biological effect? World J Gastroenterol 2018; 24(31): 3469-3471 [PMID: 30131653 DOI: 10.3748/wjg.v24.i31.3469]
URL: https://www.wjgnet.com/2307-8960/full/v24/i31/3469.htm
Number Citing Articles
1
Veysel Ersan, Bora Barut, Sezai Yilmaz. The Timing of Liver Transplantation Following Downstaging: Wait of Not to Wait?Journal of Gastrointestinal Cancer 2020; 51(4): 1152 doi: 10.1007/s12029-020-00491-z
2
Astrid Bauschke, Annelore Altendorf-Hofmann, Michael Ardelt, Herman Kissler, Hans-Michael Tautenhahn, Utz Settmacher. Impact of successful local ablative bridging therapy prior to liver transplantation on long-term survival in patients with hepatocellular carcinoma in cirrhosisJournal of Cancer Research and Clinical Oncology 2020; 146(7): 1819 doi: 10.1007/s00432-020-03215-9
3
Malin Sternby Eilard, Mats Andersson, Peter Naredi, Charalampos Geronymakis, Per Lindnér, Christian Cahlin, William Bennet, Magnus Rizell. A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantationBMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5760-8
4
Paul J. Thuluvath, Chau To, Waseem Amjad. Role of Locoregional Therapies in Patients With Hepatocellular Cancer Awaiting Liver TransplantationAmerican Journal of Gastroenterology 2021; 116(1): 57 doi: 10.14309/ajg.0000000000000999